Diagnos (ADK.V) analysis – Chris’ Corner

Today Equity.Guru founder, Chris Parry, speaks with Stefan Quenneville, Director of Life Sciences and Biotech Research…

Diagnos (ADK.V) places well in artificial intelligence competition and prepares for CARA rollout

Diagnos (ADK.V) announced that their artificial intelligence program delivered world-class results in the GAMMA (Glaucoma GrAding…

Diagnos (ADK.V) – Investor Roundtable

Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a…

Diagnos (ADK.V) latest agreement with IRIS the Vision Group aims to help Canadians see better

Diagnos (ADK.V) inked a multi-year agreement with IRIS The Visual Group 1990 to launch an artificial…

DIAGNOS (ADK.V) Enters Exclusive Distribution Agreement

DIAGNOS (ADK.V) has signed an exclusive distribution agreement with Diagnos Europe. “Our goal is to launch…

Diagnos (ADK.V) A.I. retina analysis creates a powerful early warning system for diabetics

DIAGNOS specialises in early detection of health problems based on its FLAIRE artificial intelligence (AI) platform.